Literature DB >> 26839381

Potential pathogens, antimicrobial patterns and genotypic diversity of Escherichia coli isolates in constructed wetlands treating swine wastewater.

A M Ibekwe1, Shelton E Murinda2, Chitrita DebRoy3, Gudigopura B Reddy4.   

Abstract

Escherichia coli populations originating from swine houses through constructed wetlands were analyzed for potential pathogens, antimicrobial susceptibility patterns, and genotypic diversity. Escherichia coli isolates (n = 493) were screened for the presence of the following virulence genes: stx1, stx2 and eae (Shiga toxin-producing E. coli [STEC]), heat-labile enterotoxin (LT) genes and heat stable toxin STa and STb (enterotoxigenic E. coli (ETEC), cytotoxin necrotizing factors 1 and 2 (cnf1 and cnf2 [necrotoxigenic E. coli- NTEC]), as well as O and H antigens, and the presence of the antibiotic resistance genes blaTEM, blaSHV, blaCMY-2, tet A, tet B, tet C, mph(A), aadA, StrA/B, sul1, sul2 and sul3. The commensal strains were further screened for 16 antimicrobials and characterized by BOX AIR-1 PCR for unique genotypes. The highest antibiotic resistance prevalence was for tetracycline, followed by erythromycin, ampicillin, streptomycin, sulfisoxazole and kanamycin. Our data showed that most of the isolates had high distribution of single or multidrug-resistant (MDR) genotypes. Therefore, the occurrence of MDR E. coli in the wetland is a matter of great concern due to possible transfer of resistance genes from nonpathogenic to pathogenic strains or vice versa in the environment. Published by Oxford University Press on behalf of FEMS 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  BOX AIR-1; E. coli; antimicrobial; constructed wetland; contaminants

Mesh:

Substances:

Year:  2016        PMID: 26839381     DOI: 10.1093/femsec/fiw006

Source DB:  PubMed          Journal:  FEMS Microbiol Ecol        ISSN: 0168-6496            Impact factor:   4.194


  7 in total

1.  Antibiotic resistant Escherichia coli from diarrheic piglets from pig farms in Thailand that harbor colistin-resistant mcr genes.

Authors:  Luong Thi Yen Nguyet; Krittika Keeratikunakorn; Kampon Kaeoket; Natharin Ngamwongsatit
Journal:  Sci Rep       Date:  2022-05-31       Impact factor: 4.996

2.  Diversity of Plasmids and Genes Encoding Resistance to Extended-Spectrum β-Lactamase in Escherichia coli from Different Animal Sources.

Authors:  Abasiofiok Ibekwe; Lisa Durso; Thomas F Ducey; Adelumola Oladeinde; Charlene R Jackson; Jonathan G Frye; Robert Dungan; Tom Moorman; John P Brooks; Amarachukwu Obayiuwana; Hiren Karathia; Brian Fanelli; Nur Hasan
Journal:  Microorganisms       Date:  2021-05-13

3.  Genomic Characterisation of a Multiple Drug Resistant IncHI2 ST4 Plasmid in Escherichia coli ST744 in Australia.

Authors:  Tiziana Zingali; Toni A Chapman; John Webster; Piklu Roy Chowdhury; Steven P Djordjevic
Journal:  Microorganisms       Date:  2020-06-14

4.  Impact of Vegetative Treatment Systems on Multiple Measures of Antibiotic Resistance in Agricultural Wastewater.

Authors:  Lisa M Durso; Daniel N Miller; Christopher G Henry
Journal:  Int J Environ Res Public Health       Date:  2018-06-21       Impact factor: 3.390

5.  Continuous Flow-Constructed Wetlands for the Treatment of Swine Waste Water.

Authors:  Abasiofiok M Ibekwe; Shelton E Murinda
Journal:  Int J Environ Res Public Health       Date:  2018-06-29       Impact factor: 3.390

6.  A new plasmid carrying mphA causes prevalence of azithromycin resistance in enterotoxigenic Escherichia coli serogroup O6.

Authors:  Ying Xiang; Feng Wu; Yinghui Chai; Xuebin Xu; Lang Yang; Sai Tian; Haoran Zhang; Yinxia Li; Chaojie Yang; Hongbo Liu; Shaofu Qiu; Hongbin Song; Yansong Sun
Journal:  BMC Microbiol       Date:  2020-08-11       Impact factor: 3.605

Review 7.  Performance Efficiency of Conventional Treatment Plants and Constructed Wetlands towards Reduction of Antibiotic Resistance.

Authors:  Moushumi Hazra; Lisa M Durso
Journal:  Antibiotics (Basel)       Date:  2022-01-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.